DR PHARMA
ActiveSummary
The computed 12-month bankruptcy probability of DR PHARMA is 1.7% (moderate). The 2025 annual accounts show equity of €592k and a net result of €112k. Equity is growing by ~60.3% per year across the filed fiscal years. Its solvency ranks better than 44% of 18400 sector peers (fiscal year 2025). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2025
Axes · tick = 2024
Profitability51▼-23
Solvency53▲+6
Growth78=
Track record94
Bankruptcy probability, 12 months
1.7%
Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €30k at 30 days acceptable
Liquidity short (current ratio 0.04 against 0.01 in 2024; short-term debt: 23.6% and cash: 0.9% of total assets), and 72.4% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
27.6%
Return on assets
5.2%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 10-06-2026, 51 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
51 d early
2024
59 d early
2023
9 d early
2022
30 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€112k▼ 63.7%
2024 · €309k
2022: €43klowest in 4 years
2023: €123k▲ +185% vs 2022
2024: €309k▲ +152% vs 2023highest in 4 years
2025: €112k▼ -63.7% vs 2024
2022 → 2025
Working capital
€-486k▼ 6.2%
2024 · €-458k
2022: €-632k
2023: €-648k▼ -2.5% vs 2022lowest in 4 years
2024: €-458k▲ +29.3% vs 2023highest in 4 years
2025: €-486k▼ -6.2% vs 2024
2022 → 2025
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line2022202320242025Trend
Equity€48k-€171k▲ 255%€480k▲ 181%€592k▲ 23.4%
2022: €48klowest in 4 years
2023: €171k▲ +255% vs 2022
2024: €480k▲ +181% vs 2023
2025: €592k▲ +23.4% vs 2024highest in 4 years
Operating result€91k-€123k▲ 35.3%€117k▼ 5.2%€119k▲ 2.0%
2022: €91klowest in 4 years
2023: €123k▲ +35.3% vs 2022highest in 4 years
2024: €117k▼ -5.2% vs 2023
2025: €119k▲ +2.0% vs 2024
Net result€43k-€123k▲ 185%€309k▲ 152%€112k▼ 63.7%
2022: €43klowest in 4 years
2023: €123k▲ +185% vs 2022
2024: €309k▲ +152% vs 2023highest in 4 years
2025: €112k▼ -63.7% vs 2024
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 2% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.15M
Fixed assets
€2.13M =
Current assets
€21k ▲ 247%
Equity and liabilities €2.15M
Equity
€592k ▲ 23.4%
Debt
€1.56M ▼ 5.9%
Debt's share of the balance-sheet total falls from 77.5% to 72.4%. Equity is higher and debt is lower.
Key figures and ratios
Current ratio
0.04▲
2024 · 0.01
Debt to equity
2.63▼
2024 · 3.45
ROE
18.9%▼
2024 · 64.4%
ROA
5.2%▼
2024 · 14.5%
Debt ≤ 1 year
€507k▲
2024 · €464k
Debt > 1 year
€1.03M▼
2024 · €1.17M
Income taxes
€23k▲
2024 · €20k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 35 lines
Balance sheet
Code20242025
Assets
Total assets20/58€2.13M€2.15M▲
Fixed assets21/28€2.13M€2.13M=
Financial fixed assets28€2.13M€2.13M=
Current assets29/58€6k€21k▲
Cash at bank and in hand54/58€4k€19k▲
Deferred charges and accrued income490/1€2k€2k▲
Equity and liabilities
Total equity and liabilities10/49€2.13M€2.15M▲
Equity10/15€480k€592k▲
Contributions10/11€5k€5k=
Profit (loss) carried forward14€475k€587k▲
Amounts payable17/49€1.65M€1.56M▼
Amounts payable after more than one year17€1.17M€1.03M▼
Financial debts170/4€1.17M€1.03M▼
Amounts payable within one year42/48€464k€507k▲
Current portion of amounts payable after more than one year42€137k€139k▲
Trade debts44€305€1k▲
Suppliers440/4€305€1k▲
Taxes, remuneration and social security45€35k€38k▲
Taxes450/3€26k€29k▲
Remuneration and social security454/9€10k€10k=
Other amounts payable47/48€291k€328k▲
Accrued charges and deferred income492/3€18k€16k▼
Income statement
Code20242025
Other operating charges640/8€2k€1k▼
Gross operating margin9900€119k€121k▲
Operating profit (loss)9901€117k€119k▲
Financial income75/76B€250k€50k▼
Recurring financial income75€250k€50k▼
Financial charges65/66B€38k€34k▼
Recurring financial charges65€38k€34k▼
Profit (loss) for the period before taxes9903€329k€135k▼
Income taxes67/77€20k€23k▲
Profit (loss) for the period9904€309k€112k▼
Profit (loss) for the period to be appropriated9905€309k€112k▼
Appropriation of the result
Profit (loss) to be appropriated9906€475k€587k▲
Profit (loss) brought forward from the previous period14P€166k€475k▲
The notes to these accounts (3 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Accounts by statement
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Other operating charges640/8 | - | €3k | €2k | €1k | ▼ 7.9% |
| Gross operating margin9900 | €91k | €127k | €119k | €121k | ▲ 1.9% |
| Operating profit (loss)9901 | €91k | €123k | €117k | €119k | ▲ 2.0% |
| Financial income75/76B | - | €52k | €250k | €50k | ▼ 80.0% |
| Recurring financial income75 | - | €52k | €250k | €50k | ▼ 80.0% |
| Financial charges65/66B | €48k | €22k | €38k | €34k | ▼ 9.8% |
| Recurring financial charges65 | €48k | €22k | €38k | €34k | ▼ 9.8% |
| Profit (loss) for the period before taxes9903 | €43k | €153k | €329k | €135k | ▼ 58.9% |
| Income taxes67/77 | - | €31k | €20k | €23k | ▲ 15.1% |
| Profit (loss) for the period9904 | €43k | €123k | €309k | €112k | ▼ 63.7% |
| Profit (loss) for the period to be appropriated9905 | €43k | €123k | €309k | €112k | ▼ 63.7% |
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Assets | |||||
| Total assets20/58 | €2.14M | €2.13M | €2.13M | €2.15M | ▲ 0.7% |
| Fixed assets21/28 | €2.13M | €2.13M | €2.13M | €2.13M | = |
| Financial fixed assets28 | €2.13M | €2.13M | €2.13M | €2.13M | = |
| Current assets29/58 | €18k | €6k | €6k | €21k | ▲ 247% |
| Amounts receivable after more than one year29 | €249 | - | - | - | - |
| Trade receivables290 | €249 | - | - | - | - |
| Amounts receivable within one year40/41 | €284 | - | - | - | - |
| Trade receivables40 | €0 | - | - | - | - |
| Other amounts receivable41 | €284 | - | - | - | - |
| Cash at bank and in hand54/58 | €17k | €4k | €4k | €19k | ▲ 357% |
| Deferred charges and accrued income490/1 | - | €2k | €2k | €2k | ▲ 4.7% |
| Equity and liabilities | |||||
| Total equity and liabilities10/49 | €2.14M | €2.13M | €2.13M | €2.15M | ▲ 0.7% |
| Equity10/15 | €48k | €171k | €480k | €592k | ▲ 23.4% |
| Contributions10/11 | €5k | €5k | €5k | €5k | = |
| Profit (loss) carried forward14 | €43k | €166k | €475k | €587k | ▲ 23.6% |
| Amounts payable17/49 | €2.09M | €1.96M | €1.65M | €1.56M | ▼ 5.9% |
| Amounts payable after more than one year17 | €1.44M | €1.31M | €1.17M | €1.03M | ▼ 11.8% |
| Financial debts170/4 | €1.44M | €1.31M | €1.17M | €1.03M | ▼ 11.8% |
| Amounts payable within one year42/48 | €650k | €654k | €464k | €507k | ▲ 9.2% |
| Current portion of amounts payable after more than one year42 | €134k | €136k | €137k | €139k | ▲ 1.2% |
| Trade debts44 | €29k | €31 | €305 | €1k | ▲ 301% |
| Suppliers440/4 | €29k | €31 | €305 | €1k | ▲ 301% |
| Taxes, remuneration and social security45 | €12k | €37k | €35k | €38k | ▲ 8.8% |
| Taxes450/3 | - | €27k | €26k | €29k | ▲ 12.1% |
| Remuneration and social security454/9 | €12k | €10k | €10k | €10k | = |
| Other amounts payable47/48 | €475k | €481k | €291k | €328k | ▲ 12.8% |
| Accrued charges and deferred income492/3 | - | - | €18k | €16k | ▼ 8.4% |
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €43k | €123k | €309k | €112k | ▼ 63.7% |
| Operating cash flow (approximation) | €43k | €123k | €309k | €112k | ▼ 63.7% |
| Investment in fixed assets (approximation) | - | €-3k | €0 | €0 | - |
| Change in cash | - | €-13k | €-252 | €15k | ▲ 5,900% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
10-06
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Equity above €500kEq €592k ▲23.4%
4 profitable years in a row build equity to €592k.
02-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2022net €309k ▲152%
Net result €309k, the highest in the series.
31-12
Financial
Equity above €200kEq €480k ▲181%
3 profitable years in a row build equity to €480k.
22-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Equity above €150kEq €171k ▲255%
2 profitable years in a row build equity to €171k.
30-08
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 30 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Bièvre · 1 establishment unit since 2021
Ground area
1,726 m²
Building footprint
254 m²
Parcel 91015B0300/00X007, Wallonia. Linked by address, not a title deed.
3
companies at this address
See who is registered here
1 establishment unit
DR PHARMA
since 20212.325.578.067
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 91015B0300/00X007 | Wallonia | 1,726 m² | 1 · 254 m² | - |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Juclé
BE 0676.847.984
Sint-Truiden · Eq €592,574
PHARMACIE CHARUE
BE 0866.218.413
Fleurus · Eq €591,380
PHARMACIE STOCKEL APOTHEEK
BE 0421.153.016
Sint-Pieters-Woluwe · Eq €591,084
PHARMACIE CORNIL
BE 0476.622.168
Ath · Eq €593,368
Apotheek J. Moonen
BE 0890.282.232
Lille · Eq €590,242
Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 3,294 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded17-12-2021
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Scores and ratios are computed by Checked and are not a credit decision.